Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Filings indexed 1,253 across all filing types
Latest filing 2023-05-11 Regulatory Filings
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings Classification · 60% confidence The provided document text appears to be heavily encoded or encrypted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no identifiable keywords, regulatory body references, fiscal period dates, or document titles that would allow classification into any specific filing category. Given the lack of discernible information and the fallback rule for documents that do not fit any category, the appropriate classification is Regulatory Filings (RNS). The confidence is moderate due to the inability to extract meaningful content but the clear indication that this is not a standard report or announcement.
2023-05-11 English
Regulatory Filings 2023
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify the document as any specific filing type. According to the fallback rule, when a document does not fit any specific category, it should be classified as a Regulatory Filing (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable. Therefore, the best classification is RNS with moderate confidence due to lack of readable content.
2023-05-10 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-10 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or soliciting material related to the solicitation of proxies for an annual meeting of stockholders. It includes information about the proxy contest, encourages shareholders to vote, and references the upcoming 2023 Annual Meeting of Stockholders. It also discusses the filing of a proxy statement and proxy card with the SEC. The document is not an earnings release, annual report, or management discussion but is clearly related to proxy solicitation. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length is over 6000 characters, indicating it is substantive and not just a brief announcement.
2023-05-09 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce material events or corporate changes. The text references a press release announcing first quarter 2023 financial results and a supplemental earnings presentation. It explicitly states that the information is furnished and not filed, typical for earnings releases and supplemental materials. The document does not contain full financial statements or detailed analysis itself but points to exhibits including a press release and a supplemental presentation. This aligns with an Earnings Release (ER) filing, which is the initial announcement of quarterly financial results with key highlights. The presence of a supplemental earnings presentation supports this classification. The document length and content confirm it is not a full quarterly report (IR) or annual report (10-K). Therefore, the correct classification is Earnings Release (ER).
2023-05-09 English
DFAN14A
Proxy Solicitation & Information Statement
2023-05-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.